Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FENSG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,641
Award facts
- Contract value 100% obligated
- $2,640.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,640.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is registered as a prime vendor under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products to Department of Defense healthcare facilities worldwide.
Under the PPV-G GEN V indefinite delivery contract (SPE2DR) awarded to DMS Pharmaceutical Group on November 13, 2025, with a $499,999,999 ceiling and completion date of December 31, 2036, the Defense Logistics Agency issues delivery orders for a comprehensive range of pharmaceutical products and medical consumables, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals. The contractor's established supply portfolio encompasses critical therapeutic categories ranging from oncology treatments and immunosuppressants to emergency medications and routine pharmaceuticals, positioning DMS Pharmaceutical Group as a critical supplier for Department of Defense global military healthcare operations.
Quick answers
Who was awarded contract SPE2DU26FENSG?
SPE2DU26FENSG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DU26FENSG worth?
The government has obligated $2,641 on SPE2DU26FENSG.
Is contract SPE2DU26FENSG an order under another contract?
Yes. SPE2DU26FENSG is a delivery order under SPE2DU25D9420, an indefinite delivery contract.
Was contract SPE2DU26FENSG competed?
The extent of competition for SPE2DU26FENSG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award